Although limited to precise support for cognition and related tasks, the therapeutic benefits of the current medical therapy for Alzheimer's disease using anti-dementia drugs (cholinesterase blockers and memantine) are apparent. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.